Posted: November 9th, 2023
Message from former EPLAW President and honorary member Pierre Véron: “The website of the Unified Patent Court makes available the decisions rendered by the Court, after anonymisation in accordance with the GDPR, here www.unified-patent-court.org/en/decisions-and-orders. This page allows scrolling through individual descriptive sheets with links for downloading the decisions. However, the search engine’s capabilities are limited […]
READ MOREPosted: November 6th, 2023
Menzis Zorgverzekeraar N.V. and Anderzorg N.V v. AstraZeneca B.V. and Astrazeneca AB, Supreme Court, The Hague, The Netherlands, 3 November 2023, Case No. 22/01071, with thanks to Willem Hoyng, HOYNG ROKH MONEGIER, for sending in the judgment No risk liability for patent holder AstraZeneca versus health insurer Menzis for enforcing a later retroactively invalidated patent. […]
READ MOREPosted: November 2nd, 2023
10x Genomics/Harvard v NanoString (UPC, Munich Local Division), first inter partes preliminary injunction based on the first asserted unitary patent. Request rejected based on the parent bundle patent Prof. Dr. jur. Tilman Müller-Stoy, Dr. rer. nat. Kerstin Galler, Bardehle Pagenberg, Munich Facts The applicants (10x Genomics and Harvard University) requested against the respondents (NanoString) on […]
READ MOREPosted: October 30th, 2023
President and Fellows of Harvard College v. NanoString Technologies Europe Limited, UPC Court of First Instance – Munich (DE) Central Division, 4 October 2023, Case no. UPC_CFI_252/2023 Objections based on articles 29 and 30 Brussels Ibis Regulation may be the subject of a Preliminary objection under Rule 48 in connection with 19.1(a) RoP. Preliminary objection […]
READ MOREPosted: October 25th, 2023
Arkyne Technologies S.L. v. Plant-e Knowledge B.V. and Plant-e B.V, Order of the President of the Court of First Instance, Local Division The Hague, Pursuant to R. 323 RoP (language of the proceedings), Case no. UPC_CFI_239/2023 Plant-e Knowledge B.V. and Plant-e B.V. have brought an infringement action against Arkyne Technologies. By application dated 21 September […]
READ MOREPosted: October 18th, 2023
Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A. and Regeneron Pharmaceuticals Inc v. Amgen Inc, Court of Appeal of the Unified Patent Court, appeal against dismissal of a procedural order, 13 October 2023, Case no. UPC_CoA_320/2023 Service of the Statement of claim without annexes referred to or announces therein; term extension KEYNOTES: 1. […]
READ MOREPosted: October 12th, 2023
The EPLAW Board wishes to draw attention to the EPO conference ‘Boards of Appeal and key decisions 2023’ will take place online on 9-10 November, 2023. The occasion marks the 50th anniversary of the EPC, and therefore this year online attendance is free of charge for all interested parties. No special code is required. The […]
READ MOREPosted: October 6th, 2023
Today, EPLAW hosted a webinar exclusive for its members titled ‘UPC: First Impressions and Feedback Collection’. In the course of a one-hour session, participants delved into the initial encounters with the Unified Patent Court (UPC). The session commenced with an introduction by Myles Jelf (Bristows), followed by insights shared by others including Klaus Haft (HOYNG […]
READ MOREPosted: October 1st, 2023
10x Genomic, Inc. and President and Fellows of Harvard College v. NanoString Technologies Inc., NanoString Technologies Germany GmbH, and NanoString Technologies Netherlands B.V., Court of First Instance of the Unified Patent Court, Munich Local Division, 15 September 2023, Case number UPC CFI 2/2023 The full certified English translation of the first PI based on a […]
READ MOREPosted: September 29th, 2023
Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH, UPC, Court of First Instance – Munich (DE) Central Division, Judge-rapporteur Kupecz, 20 September 2023, Case no. UPC_CFI_1/2023 Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. To be informed of the […]
READ MORE